Ana Maria Passos-Castilho

Dr. Ana Maria Passos-Castilho

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2010 in Revista da Sociedade Brasileira de Medicina Tropical
Verified
Journal Article
Open access
PDF file
MSMarli Adelina Souza
Marli Adelina Souza
APAna Maria Passos-Castilho
Ana Maria Passos-Castilho
ATArício Treitinger
Arício Treitinger
CSCelso Spada
Celso Spada
INTRODUCTION: Cytomegalovirus (CMV) infection is a matter of concern for blood bank professionals and blood transfusion recipients, especially in cases of transfusions to neonates and immunocompromised patients. Thus, the present study aimed to determine the seroprevalence of CMV IgG and IgM antibodies among blood donors in the city of Lages, in the mountain region of Santa Catarina, southern Brazil, and to investigate possible associations between the socioeconomic characteristics of donors and CMV serological status. METHODS: A seroepidemiological cross-sectional study was conducted on 1,045 blood samples from donors that were used in serological screening over a one-year investigation. All the analyses were conducted using the microparticle enzyme immunoassay with Biokit® reagents (Barcelona, Spain), in accordance with the manufacturer's instructions. RESULTS: Anti-CMV IgG seroprevalence in the sample studied was 96.4% (95% CI: 95.23 - 97.50) and that of anti-CMV IgM was 2.3% (95% CI: 1.39 - 3.20). There were no statistically significant associations between the presence of antibodies and the socioeconomic characteristics of donors. CONCLUSIONS: The blood donors in the study region had high seroprevalence of anti-CMV IgG. Thus, blood component screening strategies and careful indication for blood transfusions require special attention among healthcare professionals as part of the actions for prevention and reduction of primary infections caused by CMV.

12 March 2014 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
THTiago Hering
Tiago Hering
APAna Maria Passos-Castilho
Ana Maria Passos-Castilho
RPRenata Mello Perez
Renata Mello Perez
JBJuliana Bilar
Juliana Bilar
DFDaniel Fragano
Daniel Fragano
MFMaria Lucia Gomes Ferraz
Maria Lucia Gomes Ferraz

25 July 2015 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
APAna Maria Passos-Castilho
Ana Maria Passos-Castilho
ASAnne de Sena
Anne de Sena
AGAlexandre Geraldo
Alexandre Geraldo
CSCelso Spada
Celso Spada
CGCelso F.H. Granato
Celso F.H. Granato

1 July 2010 in Acta Haematologica
Verified
Journal Article
Closed access
APAna Maria Passos-Castilho
Ana Maria Passos-Castilho
ATArício Treitinger
Arício Treitinger
CSCelso Spada
Celso Spada
The first thrombocytopenia cases related to the human immunodeficiency virus (HIV) were described even before its isolation in 1983. Subsequently, multiple mechanisms have been proposed to elucidate the etiology of thrombocytopenia. In addition to other types of cytopenia affecting patients with HIV, thrombocytopenia is observed in about 10–50% HIV patients as one of the first clinical signs of infection. Thus, in this review we aim to summarize the mechanisms proposed for thrombocytopenia since the discovery of HIV, and especially the innovations in the field in recent years. Among the different mechanisms suggested for HIV-related thrombocytopenia, there is emphasis on the accelerated destruction of platelets (PLTs) due to the action of immune complexes, and the presence of anti-PLT and anti-HIV antibodies that cross-react with the PLT membrane. There are also secondary causes of thrombocytopenia, such as the effect of drugs and opportunistic diseases associated with HIV.

4 February 2013 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
APAna Maria Passos-Castilho
Ana Maria Passos-Castilho
THTiago Pires Heringer
Tiago Pires Heringer
JPJose Medina Pestana
Jose Medina Pestana
MFMaria Lucia Gomes Ferraz
Maria Lucia Gomes Ferraz
CGCelso Francisco Hernandes Granato
Celso Francisco Hernandes Granato

1 December 2014 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
PDF file
APAna Maria Passos-Castilho
Ana Maria Passos-Castilho
GPGilda Porta
Gilda Porta
IMIrene K. Miura
Irene K. Miura
RPRenata P. S. Pugliese
Renata P. S. Pugliese
VDVera L. B. Danesi
Vera L. B. Danesi
CGCelso F. H. Granato
Celso F. H. Granato
We describe a case of chronic hepatitis E virus (HEV) infection in a 13-year-old female liver transplant recipient with recurrent increased aminotransferase levels and acute cellular rejection. This finding demonstrates that chronic HEV infection can occur and should be further investigated in immunocompromised patients in Latin America.